CORONARY COMPUTED TOMOGRAPHY VERSUS EXERCISE TESTING IN PATIENTS WITH STABLE CHEST PAIN: COMPARATIVE EFFECTIVENESS AND COSTS

Sunday, October 23, 2011
Grand Ballroom AB (Hyatt Regency Chicago)
Poster Board # 27
(ESP) Applied Health Economics, Services, and Policy Research

Candidate for the Lee B. Lusted Student Prize Competition


Tessa S.S. Genders, MSc1, Bart S. Ferket, MD1, Admir Dedic, MD1, Tjebbe W. Galema, MD, PhD1, Nico R. Mollet, MD, PhD1, Pim J. de Feyter, MD, PhD1, Kirsten E. Fleischmann, MD, MPH2, Koen Nieman, MD, PhD1 and M.G. Myriam Hunink, MD, PhD1, (1)Erasmus University Medical Center, Rotterdam, Netherlands, (2)UCSF Medical Center, San Francisco, CA

Purpose: To determine the comparative effectiveness and costs of a CT-based strategy (CT-strategy) and a stress-electrocardiography-based strategy (standard-of-care; SOC-strategy), for diagnosing coronary artery disease (CAD).

Method: Decision analysis based on a real-world population of 471 outpatients with follow-up. All patients presented with stable chest pain and were scheduled for both stress electrocardiography (X-ECG) and coronary CT angiography (CCTA). Outcomes were correct classification of patients as CAD– (no obstructive CAD), CAD+ (obstructive CAD without revascularization) and Revascularization (using a combination reference standard based on catheter-based coronary angiography, CCTA and revascularization within 6 months), diagnostic costs, lifetime health care costs, and quality-adjusted life years (QALY).

Result: For men (and women), diagnostic cost savings were €245 (€252) for the CT-strategy as compared to the SOC-strategy. The CT-strategy classified 82% (88%) of simulated men (women) in the appropriate disease category, whereas 83% (85%) were correctly classified by the SOC-strategy. The long term cost-effectiveness analysis showed that the SOC-strategy was dominated by the CT-strategy, which was less expensive (-€229 in men, -€444 in women) and more effective (+0.002 QALY in men, +0.005 in women). The CT-strategy was less effective compared to SOC (-0.003 QALY) in men with a pre-test probability of ≥70%. When correcting for (potential) overestimation of disease by CCTA, cost-savings and gains in effectiveness were reduced.

Conclusion: Our decision analysis suggests that a CT-based strategy is superior to standard-of-care in particular for all women and for men with a pre-test probability <70%.